Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Focused Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential Focused Equity Fund |
|---|---|
| 08 Jan 2013 | ₹100.00 |
| 26 Feb 2014 | ₹106.05 |
| 17 Apr 2015 | ₹155.14 |
| 04 Jun 2016 | ₹151.43 |
| 23 Jul 2017 | ₹167.49 |
| 11 Sep 2018 | ₹177.76 |
| 30 Oct 2019 | ₹154.36 |
| 17 Dec 2020 | ₹183.94 |
| 05 Feb 2022 | ₹247.01 |
| 26 Mar 2023 | ₹237.32 |
| 13 May 2024 | ₹352.02 |
| 02 Jul 2025 | ₹415.41 |
| 20 Aug 2026 | ₹422.30 |
| Metric | ICICI Prudential · Direct · IDCW NAV ₹64.95 Very High risk ★★★☆☆ | Category median Focused Fund · 29 funds |
|---|---|---|
| +4.40% | -2.14% | |
| +15.97% | +10.43% | |
| +13.33% | +10.23% | |
| +10.05% | +7.71% | |
| +11.16% | +12.32% | |
| +12.98% | — | |
| +11.22% | +13.69% | |
| +10.28% | +12.00% | |
| +10.58% | +10.33% | |
| Risk | ||
| 13.94% | 15.25% | |
| 0.68 | 0.27 | |
| 0.93 | 0.36 | |
| -39.74% | -36.57% | |
| Nifty 500 | — | |
| +3.93% | -0.71% | |
| 0.96 | 0.96 | |
| 111.1% | 93.2% | |
| 94.3% | 97.9% | |
| 1.18% | 1.05% | |
| ₹16,230Cr | ₹2,383Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹500 | — | |
| 68% | 32% | |
| Sharmila D'silva | — | |
| 08 Jan 2013 | — | |
| 31 | — | |
| 47.7% | — | |
| 1.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.